These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3440638

  • 1. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
    Fujita K, Murayama T, Kawamura M, Narita K.
    Int J Clin Pharmacol Res; 1987; 7(6):477-80. PubMed ID: 3440638
    [Abstract] [Full Text] [Related]

  • 2. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R, Dupond JL, Peltier H, Iehl-Robert M, Henry JC.
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [Abstract] [Full Text] [Related]

  • 3. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R, Dupond JL, Mallet H, Guerber F, Iehl-Robert M, Flausse-Parrot F, Becker M.
    Nephrologie; 1986 May; 7(2):51-5. PubMed ID: 3736764
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent aminoglycoside nephrotoxicity.
    Fujita K, Sayama T, Abe S, Murayama T, Tashiro H.
    J Urol; 1985 Sep; 134(3):596-7. PubMed ID: 4032563
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R, Paternoster G, Galigani P, Giovannini L, Bertelli AA, Romano MR, Alessandrì MG, Bertelli A.
    Drugs Exp Clin Res; 1987 Sep; 13(12):751-6. PubMed ID: 3447879
    [Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 7. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
    Mozer JL, Gibey R, Dupond JL, Henry JC.
    Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
    [Abstract] [Full Text] [Related]

  • 8. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity.
    Assadamongkol K, Tapaneya-Olarn W, Chatasingh S.
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.
    Camí J, Segura J, Baños JE, Garcia I, Drobnic L.
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1013-5. PubMed ID: 7114833
    [Abstract] [Full Text] [Related]

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F, Shibazaki T, Murai S, Kodama K, Ohno I, Gomi H.
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract] [Full Text] [Related]

  • 11. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
    Guh JY, Su YH, Chen HJ, Tsai JH.
    Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
    [No Abstract] [Full Text] [Related]

  • 12. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
    Matsuoka R, Inoue T, Miyamura K, Mizutani K, Koike S, Mori H, Kigawa T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
    Hirokawa N, Naruse T.
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951
    [No Abstract] [Full Text] [Related]

  • 14. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H, Nagashima K, Okumura H, Takahashi A, Matsuyama S, Nagamachi Y.
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
    Inouye S, Niizato T, Shomura T, Kitasato I.
    Drugs Exp Clin Res; 1989 Feb; 15(5):189-209. PubMed ID: 2791871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P, Szechciński J.
    Pol J Pharmacol; 2003 Feb; 55(4):631-7. PubMed ID: 14581723
    [Abstract] [Full Text] [Related]

  • 20. N-acetyl-beta-glucosaminidase in the localization of the site of urinary tract infections.
    Chan MK.
    Singapore Med J; 1990 Apr; 31(2):135-7. PubMed ID: 2371577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.